PrIMAVeRa kick-off meeting successfully marks the official project launch
1 December, 2021 The PrIMAVeRa consortium held its Kick-off Meeting on 25 November 2021 marking the official launch of this ambitious...
top of page
NEWS
News
Search
EVI
- Dec 1, 2021
- 2 min
World AIDS Day 2021: End inequalities. End AIDS
1 December 2021 What is world AIDS day? Every year, on December 1st, the World AIDS Day provides an opportunity for the world to come...
EVI
- Nov 25, 2021
- 1 min
Open call for expert services and trainings by TRANSVAC2
Research infrastructures are an elegant solution to make science more effective and sustainable. They enable an organized, fair and...
EVI
- Nov 22, 2021
- 3 min
Antimicrobial Resistance: the silent pandemic
The annual World Antimicrobial Resistance Awareness Week (WAAW) that runs from the 18th to the 24th of November is an important event...
EVI
- Nov 9, 2021
- 3 min
PrIMAVeRa, a new ambitious project to demonstrate how vaccines can combat antimicrobial resistance
The Innovative Medicines Initiative 2 (IMI2) Joint Undertaking mobilises more than € 9 million to support PrIMAVeRa, a new public-private...
EVI
- Nov 4, 2021
- 3 min
GHIT Fund supports further clinical development of placental malaria vaccine candidates, led by EVI
Placental Malaria (PM) constitutes a major health problem. Globally, it is estimated that at least 25% of pregnant women are infected...
EVI
- Oct 18, 2021
- 2 min
Latest results from EVI-led projects, ShigOravax and PREV_PKDL, to be presented at tenth EDCTP forum
The Tenth EDCTP Forum biannually provides an international platform for the presentation and discussion of cutting-edge research...
EVI
- Oct 15, 2021
- 2 min
“A long stride down the road” – WHO recommends widespread use of malaria vaccine in African children
In what can be considered a “historic” move forward in the fight against malaria, the World Health Organization (WHO) has recommended...
EVI
- Aug 20, 2021
- 2 min
Malaria vaccine candidate PfAMA1 DiCo demonstrates broadening of immune responses
Despite significant progress achieved in the past years, malaria remains a major cause of morbidity and mortality, especially in children...
EVI
- Jul 29, 2021
- 4 min
EVI to lead Inno4vac, a new European public-private partnership to innovate vaccine development
The Innovative Medicines Initiative 2 (IMI2) Joint Undertaking mobilised more than € 38.5 million to support Inno4vac, an innovative...
EVI
- Jun 21, 2021
- 3 min
EVI signs MoU with CEPI
EVI and CEPI signed a Memorandum of Understanding that establishes a vaccinology training collaboration with the TRANSVAC2 project.
EVI
- Jun 16, 2021
- 4 min
A safe, effective and affordable Zika vaccine
Zika virus infection is a vector borne disease which has called the attention of the international community due to a large outbreak in...
EVI
- Apr 28, 2021
- 3 min
European Immunization Week 2021
‘Vaccines bring us closer’ across the world, organisations and generations This year, under the theme ‘Vaccines bring us closer’, both...
EVI
- Apr 27, 2021
- 3 min
Vaccines, bringing us closer to fighting today’s diseases and tomorrow’s threats
World Immunization Week: 24 – 30 April 2021
Vaccines protect people of all ages against disease.
EVI
- Apr 23, 2021
- 2 min
World Malaria Day 2021: Reaching the zero malaria target by 2030
The World Malaria Day on April 25th marks the progress in fighting malaria, highlighting the responsibility we all have to end this...
EVI
- Mar 23, 2021
- 2 min
World Tuberculosis Day 2021 - “The clock is ticking”...
...to develop the next generation of safe, affordable and effective TB vaccines TBVI and EVI are building on a strong TB vaccine R&D...
EVI
- Mar 9, 2021
- 2 min
Effective vaccine against placental malaria: Where we are and what does the future hold?
A new review article on Placental Malaria has been published in Frontiers in Immunology. The publication, entitled Progress and Insights...
EVI
- Feb 17, 2021
- 2 min
EVI to lead Immune Monitoring in pan-European vaccine trial network, VACCELERATE
EVI to lead Immune Monitoring in pan-European vaccine trial network, VACCELERATE, as part of €150 million EU investment in research to...
EVI
- Feb 11, 2021
- 2 min
International Day of Women and Girls in Science 2021
February 11th marks the International Day of Women and Girls in Science. It is an opportunity to promote full and equal access and...
EVI
- Feb 10, 2021
- 1 min
PREV_PKDL and CREDO projects join forces to strengthen flow cytometry capacity in Africa
Knowledge sharing and capacity building are key to advance scientific research and innovation. One of the main objectives of the...
EVI
- Feb 4, 2021
- 1 min
VAC2VAC at the scientific conference “Towards replacement of animals for scientific purposes”
The VAC2VAC project was presented on February 3rd, 2021 at the scientific conference “Towards replacement of animals for scientific...
EVI
- Jan 29, 2021
- 2 min
World NTD day 2021
Every year on January 30th, the global health and development community comes together to acknowledge World Neglected Tropical Disease...
EVI
- Jan 27, 2021
- 3 min
New report finds PDPs serving neglected communities produced dozens of life-saving innovations
Novel approach for minimizing investment risks and stretching limited budgets has 375 infectious disease innovations under development...
EVI
- Jan 13, 2021
- 1 min
McKinsey & Company awarded subcontract by EVI
The European Vaccine Initiative (EVI) has selected McKinsey & Company to develop a business plan, including suitable governance structure...
bottom of page